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The MHC Reactivity of the T Cell Repertoire
Prior to Positive and Negative Selection
Jens Zerrahn,* Werner Held,† triggering of a low but sufficient fraction of T cells, often
estimated as 1025–1024 T cells per foreign peptide.and David H. Raulet
A mysterious and striking feature of the T cell reper-Department of Molecular and Cell Biology
toire is its reactivity with cells bearing foreign MHC mole-Cancer Research Laboratory
cules (alloreactivity), manifested by frequencies of 1022–University of California
1021 T cells reacting to cells bearing any one foreignBerkeley, California 94720
MHC molecule (Fischer-Lindahl and Wilson, 1977). Allo-
reactive T cells are included in the set that reacts to
foreign peptide/self-MHC complexes (Bevan, 1977;
Summary Ashwell et al., 1986). Alloreactivity may result from the
large number of MHC/cellular peptide complexes found
T cell antigen receptors (TCRs) on mature T cells react on normal cells, estimated as .2000 (Hunt et al., 1992),
with peptide antigens presented by self-MHC proteins to which a responding allogeneic T cell population is
and also frequently cross-react with foreign MHC pro- not tolerant. The frequency of T cells that reacts with
teins. The fundamentalquestion whether MHC reactiv- any one such complex is thought to be very low, since
ity is inherent in the germline TCR sequences or is the T cells were not positively selected to recognize this
imposed by thymic selection was addressed here by MHC molecule. Yet the the additive frequency of T cells
inducing nonselective maturation of immature thymo- reactive with all such complexes on the allogeneic cell
cytes in the absence of MHC molecules. MHC reactiv- may be very high (Matzinger and Bevan, 1977).
ity in the preselection repertoire is very high, but no While recent studies have shed much light on how
higher than in the normal repertoire. Cross-reactivity positive and negative selection shape the repertoire (Ro-
of clones with multiple MHC molecules occurred to a bey and Fowlkes, 1994; Jameson et al., 1995), little is
similar extent in the preselection and MHC-selected known concerning the starting point for selection, i.e.,
the preselection repertoire. A fundamental issue isrepertoires. The results establish the MHC reactivity
whether and to what extent interactions with MHC mole-of the germline TCR repertoire, indicate the minimum
cules are ingrained in the germline sequences of TCRs.fraction of immature thymocytes that must undergo
Is the preselection repertoire biased to recognize MHCnegative selection, and suggest that some TCR–MHC
molecules (Jerne, 1971), and if so, to what extent? Re-contacts may be conserved.
cently, it has been established that the TCR contacts
the a1 and a2 domains of the MHC molecule (Hong et
Introduction al., 1992; Ehrich et al., 1993; Garboczi et al., 1996; Garcia
et al., 1996; Sim et al., 1996). Although the sequences
T cell antigen receptors (TCRs) recognize peptides of of the CDR1 and CDR2 regions of TCR a and b chains
foreign protein antigens complexed with self-MHC (ma- are germline encoded, many of the amino acids in the
jor histocompatibility complex) molecules. Indeed, the third CDRs are nongermline encoded, as a consequence
mature T cell repertoire is biased toward recognition of of random processes operating during V(D)J recombina-
foreign peptides associated with self-MHC molecules, tion. Furthermore, the particular combination of a and
as opposed to those associated with nonself-MHC mol- b chains is randomly chosen in a given T cell, and it is
ecules. This characteristic is imposed by positive selec- unclear to what extent interactions between the chains
tion of developing T cells as they mature in the thymus could alter the conformation and, consequently, the
MHC specificity of a TCR. In principle, these random(Jameson et al., 1995). At the same time, a negative
components of the receptors could play a large role inselection process purges the T cell repertoire of cells
determining their ultimate specificity for antigen as wellthat are reactive with complexes of thymic self-peptides
as for MHC molecules.with self-MHC molecules (Robey and Fowlkes, 1994).
On one extreme, the preselection repertoire might beIt is thought that positive selection favors immature
completely random in its specificities; the propensity ofCD41CD81 thymocytes that bind weakly or strongly to
TCRs on mature T cells to react with MHC moleculesself-MHC/peptide complexes, whereas negative selec-
may result wholly as a consequence of positive selec-tion induces the death of thymocytes that bind strongly
tion, which demands MHC-reactive cells. In this scheme,to self-MHC/peptide complexes (Ashton-Rickardt et al.,
only rare clones in the preselection repertoire should be1994; Hogquist et al., 1994). Operating together, positive
subject to thymic selection. At the other extreme, theand negative selection yield a repertoire of T cells that
preselection repertoire might be even more strikinglybind too weakly to self-MHC/self-peptide complexes for
MHC-reactive than the mature repertoire, includinginduction of immune responses. Binding contacts of the
many clones that cross-react on several different orTCR with a foreign peptide in the groove of a self-MHC
even all MHC molecules (Ignatowicz et al., 1996). In thismolecule may provide the added affinity necessary for
scheme, many clones are subject to positive selection,
and a large fraction of those are also subject to negative
selection, including the MHC cross-reactive clones.* Present address: Max-Planck Institute, Monbijou-Haus, Monbi-
These schemes and others could give rise to the ob-joustrasse 2A, 10117 Berlin, Germany.
served mature repertoire. Resolving among these possi-†Present address: Ludwig Institute For Cancer Research, Lausanne
Branch, Ch. des Boveresses 155, 1066 Epalinges, Switzerland. bilities is central to understanding the relative roles of
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reactivity of cells observed in all of these experiments
could have been the result of positive selection.
We have directly examined the repertoire of T cell
specificities that arises in the absence of MHC expres-
sion. In mice deficient for both MHC I and MHC II mole-
cules (MHC IoIIo mice), T cell development is blocked at
the CD41CD81TCRab1 stage (Chan et al., 1993; Grusby
et al., 1993). These cells represent the developing T cell
receptor repertoire prior topositive or negative selection
by MHC molecules. Like CD41CD81 thymocytes in nor-
mal mice, these cells are immature; they fail to proliferate
in response to stimulation through the TCR in vitro (Ro-
bey and Fowlkes, 1994) and do not yield stable hybrido-
mas at significant frequencies (data not shown). In fetal
thymic organ cultures, these cells can be efficiently in-
duced to mature by providing anti-TCRab and anti-CD4
Figure 1. Development of CD41CD8- T Cells in MHC IoIIo Fetal Thy- MAbs. Analysis of the specificity of these cells provides
mic Organ Culture Induced by Anti-TCRab MAb and Enhanced by a quantitative analysis of the MHC reactivity of the pre-
Anti-CD4 MAb selection repertoire.
Day 16 fetal thymii from MHC IoIIo mice were placed in organ culture
and treated with either 10 mg/ml anti-TCRab MAb H57-597, 30%
supernatant containing anti-CD4 MAb GK1.5, or both. After 6 days
Resultsof culture, the percentages (left panel) and numbers (right panel) of
CD41CD81 T cells in the respective organcultures were determined.
The data represent the mean of two independent experiments and An Organ Culture System to Stimulate Maturation
the ranges. of CD41CD81 Thymocytes in the Absence
of MHC Expression
As a means to stimulate maturation of CD41CD81 thy-
mocytes in MHC IoIIo mice, we tested the effects of add-positive and negative selection in shaping the ultimate T
cell repertoire. These issues also bear on the TCR–MHC ing soluble anti-TCRab MAb (H57–597) to MHC IoIIo fetal
thymic organ cultures (Takahama et al., 1994). After 6interaction per se, because inherent MHC reactivity of
the preselection repertoire would suggest that there may days of organ culture, the antibody treatment resulted
in an increase of 5- to 10-fold in the number ofbe some conserved contacts between nonvariable por-
tions of the TCRs and MHC molecules. TCRab1CD41CD82 and CD42CD81 thymocytes, com-
pared to the number that appeared without addition ofThe available information concerning the specificity
of thepreselection repertoire is intriguing,but it is largely antibody (Figure 1). Since the number of mature T cells
was still limiting, we investigated whether simultaneousbased on indirect analyses of selected T cells or their
TCRs. It was shown that random combinations of TCR stimulation of the CD4 coreceptor with anti-CD4 MAbs,
along with stimulation of the TCR, would augment thea and b chains, generated by fusions of hybridomas,
were often alloreactive with another MHC molecule differentiation of mature T cells in the organ cultures
(Punt et al., 1993). The anti-CD4 MAb had no effect in(Blackman et al., 1986). Because each of these chains
had come from cells that may have been previously the absence of anti-TCRab MAb (Figure 1). In cultures
containing both MAbs, there was no significant en-subjected to thymic selection, it was possible that their
MHC specificity had been previously selected for. More hancement in the number of CD42CD81TCRab1 thy-
mocytes, but the appearance of CD41CD82 cells wasrecent studies examined the T cell repertoires in mice
in which thymic selection was directed by one or a few enhanced by 4- to 5-fold, corresponding to an overall
27-fold increase in the number of these cells comparedpeptide/MHC complexes (Ignatowicz et al., 1996; Miya-
zaki et al., 1996). As numerous mature T cells arose as to cultures without antibodies (Figures 1 and 2, Table
1). The cultures treated with both antibodies containeda consequence of positive selection with one or a few
complexes, it was proposed that the frequency of MHC- as many, or more, CD41CD82 cells as MHC IoII1 thymus
organ cultures run in parallel without antibody addition.reactive precursors must be reasonably high (Ignato-
wicz et al., 1996). Furthermore, it was observed that Most of the CD41 T cells selected by the antibody
mixture (“antibody-selected CD41 T cells”) expressedmany of the T cells arising from thymic selection by a
single MHC/peptide complex exhibited a surprisingly the TCRab and were phenotypically mature (i.e., HSA2)
(Figure 2). Furthermore, most of these cells exhibitedhigh degree of reactivity to MHC-matched cells express-
ing diverse cellular peptides, as well as cross-reactivity the CD44(Pgp-1)2 CD252 CD692 cell surface phenotype
of resting, naive T cells, strongly suggesting that theyto different allogeneic MHC molecules. The high fre-
quency of these clones raised the possibility that many had not arisen by antibody-driven expansion of a few
precursors (Figure 2). The failure of the CD4 antibodyclones in the preselection repertoire are broadly MHC
cross-reactive (Ignatowicz et al., 1996). Another study by itself to stimulate the differentiation of CD41CD82
thymocytes suggests that the effects of the anti-TCRemployed transgenic mice to achieve a situation where
thymocytes underwent positive selection directed by antibody are specific. Sufficiently large numbers of
CD41CD82 cells differentiated in these antibody-treatedthe normal array of MHC/peptide complexes, but not
negative selection. A high frequency of the resulting T MHC IoIIo fetal thymic organ cultures for subsequent
analysis of their function and specificity.cells reacted to self-MHC (Laufer et al., 1996). The MHC
MHC Reactivity of the Preselection TCR Repertoire
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Table 1. Generation of CD41CD82 T cells in MHC IoIIo FTOC by Antibody Treatment
IoII1 FTOC IoIIo FTOC IoIIo FTOC 1 aTCR/aCD4
Number of Experiments 2 4 4
Cells/Thymus [3 1023] 255.0–800.0 163.0–380.0 155.0–390.0
CD41CD82
% of Thymocytes 13.8–18.9 0.7–2.9 17.7–59.0
Number per Thymus [3 1023] 48.2–110.4 1.1–6.1 63.7–112.5
CD81CD42
abTCR1 % of Thymocytes 1.1–3.2 0.3–1.1 2.9–7.8
Number per Thymus [3 1023] 8.2–9.0 1.1–2.4 9.5–29.0
gdTCR1 % of Thymocytes 1.5–4.1 3.9–5.6 2.3–4.6
Number per Thymus [3 1023] 10.4–12.1 8.9–19.5 6.7–12.3
CD41CD81
% of Thymocytes 42.2–77.1 67.2–84.4 7.6–66.0
Number per Thymus [3 1023] 107.0–616.0 119.0–295.0 32.6–257.0
Cell suspensions from the indicated fetal thymic organ cultures (FTOC) were analyzed for expression of CD4, CD8, and T cell receptor ab or
gd expression. The data represent the range of the indicated number of experiments. Essentially all of the CD41CD82 thymocytes in all groups
expressed TCRab.
The Antibody-Selected CD41 Thymocytes by analyses of the Vb and Va usage (Figure 3). Vb and Va
frequencies among antibody-selected CD41CD82 cellsRepresent the Preselection Repertoire
Because the anti-TCRab MAb is not known to discrimi- were similar to those of CD41CD81 cells from MHC IoIIo
organ cultures, those that were treated with the antibodynate between different TCRs, the repertoire selected by
the antibody mixture is likely to be representative of the mixture, or control cultures that were not antibody
treated (Figure 3). In some cases, these frequenciespreselection repertoire. This contention was supported
Figure 2. Phenotype of Antibody-Selected CD41CD8- T Cells Derived from MHC IoIIo Thymic Organ Cultures
Flow cytometric analyses of gated CD41CD82 thymocytes that developed in fetal thymic organ cultures from MHC IoII1 mice (MHC II–selected),
from MHC IoIIo mice (unselected), or from MHC IoIIo mice with the addition of anti-TCRab and anti-CD4 MAbs (antibody-selected). Shown for
comparison are thymocytes from adult MHC I1II1 mice. Thymocytes were stained for CD4, CD8, and either TCRab, HSA, CD69, CD44 (Pgp-1),
CD25, or TCRgd (data not shown, see Table 1.). Isotype-matched antibodies were used as negative controls. Note that a substantial fraction of
the CD42CD81 thymocytes observed in these organ cultures were either TCR2 (data not shown) or expressed TCRgd rather than TCRab (Table 1).
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Figure 3. The TCR Variable Region Usage by
Antibody-Selected CD41CD82 T Cells Differs
from That of MHC II–Selected CD41CD82 T
Cells
Organ cultures were prepared with day 16
fetal thymii from MHC IoII1 or MHC IoIIo mice.
The MHC IoIIo organ cultures were incubated
with or without anti-TCR/anti-CD4 MAbs; the
MHC IoII1 organ cultures were incubated
without antibodies. After 6 days, the propor-
tion of gated CD41CD82 or CD41CD81 T cells
expressing individual TCR Vb or Va elements
were determined by three-color flow cytome-
try. Percentages given for CD41CD81 T cells
were adjusted based on the proportion of
cells that stained positively with anti-TCRab
MAb H57-597. The results represent the
mean 6 SD of 3 (CD41CD82 cells) or 2
(CD41CD81 cells) independent determina-
tions.
differed considerably from those of CD41CD82 thymo- can induce maturation of MHC I–specific thymocytes
into CD41CD82 cells, even in the absence of the normalcytes from MHC II1 fetal thymic organ cultures (“MHC
II–selected CD41 T cells”). The MHC II–selected CD41 selecting ligand(s) for the corresponding TCRs.
cells contained a higher number of Vb21 and, especially,
of Vb141 CD41CD82 cells, suggesting that these cells MHC Reactivity of Antibody-Selected Thymocytes
A limiting dilution analysis (LDA) of proliferating CD82are preferentially positively selected by IAb. Previous
findings suggested that Vb141 T cells are favored for (predominantly CD41) thymocytes was employed as one
means to assess MHC reactivity of the selected thymo-positive selection by IAb, compared to positive selection
by the Kb and Db class I molecules (Liao et al., 1989). T cytes (Figure 5). An average of 1/498 of the antibody-
selected CD41 T cells responded to H-2q stimulatorcells expressing Vb3, Vb6, Vb9, Vb11, and Vb13 were
more frequent in the antibody-selected repertoire than cells. H-2q molecules fail to present endogenous super-
antigens (Herman et al., 1991), and therefore, it is likelyin the MHC II–selected repertoire. The B6/B10 strains
express the endogenous mammary tumor virus– that the observed responses were directed at MHC mol-
ecules rather than at superantigens (and see below). Aencoded Mtv-8, Mtv-9, and Mtv-17 superantigens. Pre-
vious studies document that Vb111 and Vb131 T cells similar frequency of antibody-selected T cells (1/546)
also reacted against “self” H-2b (MHC Io) stimulator cells.undergo clonal deletion in mice expressing these super-
antigens (Braun et al., 1995; Scherer et al., 1995), sug- These responses were specific for the Ab MHC II mole-
cule, since there was no reaction against the H-2b MHCgesting that the higher frequency of these cells in the
antibody-selected repertoire is due to their failure to IoIIo stimulator cells that were used as the baseline for
the LDAs. The absence of tolerance to H-2b molecules,undergo superantigen-induced clonal deletion in the
MHC2 thymii. The higher frequency of Vb31, Vb61, and defined as self by the parents of the MHC IoIIo mice,
would be expected of the preselection repertoire. TheVb91 cells in the antibody-selected repertoire could re-
flect a previously undetected superantigen reactivity of
these Vbs, or could be due to inefficient positive selec-
tion of cells expressing these Vbs by IAb MHC molecules.
As a means to address directly whether the antibody
selection procedure operates independently of the MHC
specificity of TCRs on selected cells, we determined
whether the antibodies induce thymocytes expressing
an MHC I–specific TCR to mature inappropriately into
CD41CD82 thymocytes. Mice expressing a transgene-
encoded TCR specific for HY antigen presented by the
Db class I molecule were crossed onto an MHC Io back-
ground in order to prevent expression of the selecting Figure 4. Antibody-Mediated Selection of CD41CD82 Thymocytes
Db class I molecule. Cultures of HY-TCR transgenic/ Expressing an MHC Class I–Specific Transgenic TCR in a Nonselec-
MHC Io fetal thymii in the presence of anti-TCR and tive (MHC IoII1) Background
anti-CD4 MAbs resulted in a substantial increase in the Day 16 fetal thymii from HY-TCR-transgenic, MHC IoII1 mice were
cultured alone (left panel) or with the addition of the anti-TCR/anti-number of CD41CD82 thymocytes, which stained with
CD4 MAb mixture (right panel). After 6 days, gated CD41CD82 TT3.70 MAb specific for the transgene-encoded TCR and
cells were analyzed for expression of the maturation marker HSAwere mature based on their HSA2 phenotype (Figure
and the transgenic TCR, revealed by clonotypic MAb T3.70, by four-4). Control organ cultures lacking the MAbs contained
color flow cytometry. Averaging the results of three determinations,
some CD41CD82 cells, but these were largely T3.702, the antibody treatment resulted in a 4.6-fold increase in the absolute
indicating that they expressed endogenously encoded numberof CD41CD82T3.701 thymocytes per thymic lobe, compared
to control cultures.TCRs. These data indicated that the antibody mixture
MHC Reactivity of the Preselection TCR Repertoire
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Figure 5. MHC-Reactive T Cells Are as Fre-
quent in the Antibody-Selected Population as
in the MHC II–Selected Population
Limiting dilution analysis (LDA) was em-
ployed to determine precursor frequencies of
MHC-reactive T cells from antibody-treated
MHC IoIIo or untreated MHC IoII1 organ cul-
tures after depletion of CD81 cells. Stimulator
cells were irradiated spleen cells from MHC
IoII1 (H-2b), DBA/1J (H-2q), or IoIIo (H-2b) mice.
The latter cells were used as negative con-
trols to determine the background of the LDA,
and essentially all of the wells yielded very
low cpm. Results of three independent exper-
iments and the mean are shown (right panel),
as well as the graphic depiction of experiment
2 (left panel). The 95% confidence intervals
for the frequency determinations for experiments 1–3 were: 1/578–1/940, 1/328–1/515, and 1/655–1/1242 for MHC II–selected cells versus
H-2b; 1/427–1/470, 1/263–1/408, and 1/534–1873 for antibody-selected cells versus H-2q; and 1/402–1/601, 1/216–1/335, and 1/504–1/812 for
antibody-selected cells versus H-2b.
frequencies of MHC-reactive cells observed in the anti- H-2 haplotype, excluding those that exhibited reactivity
with endogenous superantigens (see below). In compar-body-selected repertoire were similar to the frequency
of control MHC IIb–selected CD82 thymocytes that pro- ison, 5.4% of the hybrids representing the MHC II–
selected repertoire reacted with a given H-2 haplotype,liferated in response to allogeneic DBA/1J (H-2q) stimu-
lator cells (1/720). These frequencies are within the re- excluding the H-2b (self) stimulator cells that did not
stimulate any of these hybrids. In terms of MHC reactiv-ported range (Ceredig et al., 1983; Itoh et al., 1990), but
underestimate the frequency of MHC-reactive cells in ity, there was no statistically significant difference be-
tween these hybridoma sets (p . 0.1 by x2 test). Hybridsthe repertoire due to imperfect plating efficiencies in
LDAs. As expected, the MHC IIb–selected thymocytes representing each repertoire were reactive with each
stimulating MHC haplotype tested, with the exceptiondid not respond to self (H-2b MHC Io) stimulator cells.
To extend the analysis of the antibody-selected reper- of the MHC II–selected hybrids responding to H-2b (self)
stimulator cells, where no responses were detected (Fig-toire, a panel of T hybridomas was prepared from anti-
body-selected CD41 T cells, or control MHC II–selected ure 6A). The antibody-selected repertoire was not toler-
ant to H-2b stimulator cells, as a similar frequency ofCD41 T cells, after activating the cells with immobilized
anti-TCR and costimulating anti-CD28 antibodies. As these hybrids reacted against H-2b stimulator cells and
non-H-2b stimulator cells (Figure 6B). These results dem-fusion partner, we employed the TCRa2 and b2 variant
of BW5147 (White et al., 1989). Hybridomas that stained onstrated that the predilection for MHC reactivity is high
in the antibody-selected repertoire.However, in contrastpositively with anti-TCRab and anti-CD4 MAbs and that
produced IL-2 in response to anti-TCRab stimulation to the predictions of Ignatowicz et al. (Ignatowicz et al.,
1996), MHC reactivity in the antibody-selected reper-were further tested for MHC reactivity. Each hybrid was
stimulated with splenic cells from 10 different strains, toire was not substantially higher than observed in the
MHC-selected repertoire.representing 8 independent MHC haplotypes (Figure 6).
Only 1–2 hybrids from either collection responded to If the observed responses represented reactivities to
endogenous mammary tumor virus (Mtv) genome–negative control MHC IoIIo stimulator cells, and these
were discarded. A total of 38 reactive hybridomas was encoded superantigens presented by MHC molecules,
our conclusions would be misleading. We examinedstained with a panel of 10 anti-Vb antibodies, revealing
positive staining in 28 instances (see Figure 6 for Vb whether the hybrids that were stimulated with B10.BR
(H-2k) stimulator cells could also be stimulated with cellsassignments). Most of the reactive hybrids were clonal,
based on the observation that 27 of 28 reactive hybrids from an H-2k mouse strain that had been bred free of
endogenous superantigens (Scherer et al., 1995). Hy-in bothsets that stained with a given Vb antibody stained
uniformly with that antibody. No evidence was found for brids that respond to B10.BR but not to the Mtv2 H-2k
stimulator cells are likely to be superantigen-reactive.expression of multiple Vbs by a given hybridoma clone,
based either on costaining with 2 anti-Vb antibodies or It was found that 3 of the 7 B10.BR-reactive hybrids
representing the antibody-selected repertoire were su-comparisons of the ratio of staining intensity of different
hybridomas with a given anti-Vb antibody versus anti- perantigen reactive, as were 2 of the 6 B10.BR-reactive
hybrids from the MHC II–selected repertoire (listed inTCRb antibody. Hybridomas from set 1 of each panel
were tested against both MHC IoII1 and MHC I1II1 stimu- Figure 6, bottom entries). One of the superantigen-reac-
tive hybrids from the antibody-selected repertoire ex-lator cells of the relevant H-2b, H-2d, or H-2k haplotypes,
and all proved to be MHC II reactive; MHC II reactivity pressed Vb5.1 and/or Vb5.2, previously shown to react
with Ek and either the Mtv-8 or Mtv-9 superantigensis to be expected, based on the expression of the class
II–specific CD4 coreceptor by the hybridomas. that are expressed in B6/B10 mice (Braun et al., 1995;
Scherer et al., 1995). The other Mtv superantigen–An average of 5.7% of the hybrids representing the
antibody-selected repertoire responded to any given reactive hybrids expressed Vb3, Vb8, or undetermined
Cell
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Figure 6. Pattern of MHC Reactivity of Hybridomas Prepared from Antibody-Selected and MHC II–Selected CD41CD82 Thymocytes
Hybridomas were stimulated with the indicated spleen cells, and IL-2 in the supernatant was tested with the CTLL-2 bioassay. Closed boxes
indicate a positive reaction (cpm at least 4-fold over background with H-2b MHC IoIIo spleen cells), (2) indicates a negative reaction (most of
these were close to background), and open boxes were not tested. One or two hybrids from each panel secreted IL-2 upon challenge with
H-2b MHC IoIIo spleen cells, which served as negative control; these are not depicted. All of the hybridomas produced abundant IL-2 in
response to plate-bound anti-TCRab (MAb H57-597) stimulation (data not shown). The data represent a compilation of several experiments.
Expression by MHC reactive hybridomas of TCR Vb 2, 3, 5, 6, 7, 8, 9, 11, 13, or 14 was determined by flow cytometry. Hybridomas expressing
none of these Vb elements are indicated with (x), and (ND) indicates not determined. The MHC II–selected hybridoma panel was derived from
two sets of fusions (set 1: #1–20, and set 2: #21–60), whereas the antibody-selected hybridoma panel was derived from three sets of fusions
(set 1: #1–17, set 2: #18–27, and set 3: #28–64).
Vbs. The Mtv/H-2k–reactive hybrids were excluded from any of the remaining MHC reactive clones are reactive
to B6/B10–derived superantigens.calculations of MHC reactivity. Since the IEk class II
molecule presents all tested endogenous superantigens A question of some interest is whether the antibody-
selected repertoire contains a subset of clones thatvery effectively (Herman et al., 1991), it is unlikely that
MHC Reactivity of the Preselection TCR Repertoire
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These CD41 cells were of resting, naive cell surface
Table 2. Distribution of MHC Reactivities in the Antibody-
phenotype, suggesting that they arose by maturationSelected Repertoire
as opposed to postmaturation expansion of a few pre-
Number of MHC Predicted from Poisson cursor cells. Significantly, the anti-CD4 MAb enhanced
Reactivities/Hybrid Observed Distribution
the differentiation of only CD41 thymocytes, not CD81
0 42 38.6 thymocytes. These data suggest that coreceptor signal-
1 14 17.7 ing induced by the anti-CD4 antibody promotes positive
2 2 4.1
selection, just as MHC-induced coreceptor signalingen-3 2 0.6
hances positive selection in vivo. This system may there-4 1 0.1
fore be useful for subsequent studies of TCR and core-
Sum 61 61
ceptor signaling in positive selection.
The observed distribution is not significantly different from the pre-
dicted one, x2 5 1.09, p . 0.1 (for statistical analysis, the 2, 3, and
The Antibody-Selected Repertoire4 reactivity groups were combined to validate the calculations). Mtv
superantigen–reactive hybridomas were omitted for the calcula- Because the antibody-selected repertoire is created in
tions. MHC-deficient mice, it is likely to resemble the prese-
lection repertoire. A caveat is that the MHC-deficient
mice express very low levels of class I molecules (Bix
and Raulet, 1992). However, these levels are too lowcross-react promiscuously with several or many MHC
to stimulate appreciable levels of T cell developmentmolecules. Hybrids reactive with up to 3 or 4 of the 8
(Zijlstra et al., 1990). Although it is formally possible thattested H-2 haplotypes were present in both hybridoma
the mice could also express very low levels of an AaEbsets. In most or all of these cases, multireactivity was
dimeric class II molecule, attempts to detect this mole-due to cross-reactivity rather than lack of clonality, be-
cule have met with failure (Cosgrove et al., 1991). In anycause 3 of 5 multireactive hybrids in each hybridoma
case, several features of our data strongly support theset stained uniformly with one of the Vb antibodies
contention that the antibody-selected repertoire is rep-tested; the remaining 2 multireactive hybrids in each set
resentative of the preselection repertoire. First, the Vbdid not stain with any of the Vb antibodies tested. While
and Va distribution was similar to that of CD41CD81MHC multireactivity was clearly observed, a statistical
thymocytes present in MHC IoIIo thymic organ cultures,analysis suggests that it occurs largely at random. If
yet differed considerably in several respects from thatthe reactivities were distributed randomly, the pattern
of MHC II–selected CD41 T cells. Second, as would beshould follow the Poisson distribution, which predicts
expected of the preselection repertoire, the antibody-that the observed 28 MHC reactivities in the antibody-
selected repertoire contained clones reactive with H-2bselected repertoire should be distributed among the 61
MHC molecules, which defines self for the parents ofhybrids, as depicted in Table 2. As assessed by the
the MHC IoIIo mice (Figures 5 and 6). Third, the antibodyx2 test, the observed distribution of reactivities was
selection protocol caused the maturation of T cells ex-indistinguishable from the predicted distribution (p .
pressing the MHC I–restricted HY-specific TCR into the0.1, Table 2). Thus, there is no indication from this analy-
CD41 compartment, in the absence of the Db-selectingsis that reactivity with multiple MHC molecules occurs
ligand for the HY-TCR. Taken together, these findingsat a higher than expected frequency in the preselection
indicate that the antibody-selected repertoire is inde-repertoire.
pendent of MHC expression and representative of the
preselection repertoire that exists in the fetal thymus.Discussion
Positive Thymic Selection Mediated MHC Reactivity of the Preselection Repertoire
Collectively, the results of theLDAs and hybridoma anal-by Anti-TCR and Anti-CD4 MAbs
In line with an earlier report (Takahama et al., 1994), we ysis suggest that the preselection repertoire exhibits a
high reactivity with MHC-expressing cells. The LDAs andobserved that soluble anti-TCRab MAbs added to a
fetal thymic organ culture from MHC-deficient mice can hybridoma analysis demonstrated a similar frequency of
MHC-reactive cells in the antibody-selected and MHCstimulate maturation of CD41 thymocytes. In the earlier
study, it was emphasized that the effectiveness of the II–selected repertoires. However, the LDAs yielded a 25-
fold lower estimate of the frequency of MHC-reactivetreatment depended on the anti-TCRab antibody being
in a soluble and unaggregated form, or it would other- cells than the hybridoma analysis. In similar LDAs with
TCR-transgenic CD81 T cells, we observed that the plat-wise cause clonal deletion. Thus, a relatively low level
of TCR signaling by the bivalent anti-TCRab MAb ap- ing efficiency was only about 10%, suggesting that the
frequencies based on the hybridoma analysis are morepears to substitute for the low affinity multivalent inter-
action thought to stimulate positive selection in vivo. accurate than those from the LDA (data not shown).
Based on the hybridoma analysis, the average percent-Our results extend the earlier findings, as we observed
that not only CD41, but also CD81 thymocyte maturation age of hybrids from the antibody-selected repertoire
that were reactive with a given MHC class II1 stimulatorwas induced by anti-TCRab MAbs. We found that solu-
ble anti-CD4 MAbs strongly enhanced the anti-TCR- cell was 5.7%, similar to the 5.4% observed in the MHC
II–selected repertoire. Correcting for the fact that someinduced maturation of CD41 thymocytes in MHC IoIIo
thymic organ cultures, as had been previously demon- of the stimulator cells present two class II molecules (IA
and IE), while others present only one (IA), an averagestrated in MHC1 thymic organ cultures (Punt et al., 1993).
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of 4.4% of the hybrids in the antibody-selected reper- we propose that a single peptide/MHC complex must
select a relatively small fraction of the preselection rep-toire was reactive against a given class II molecule,
compared to 3.4% in the MHC II–selected repertoire. ertoire, which accumulates under steady state condi-
tions to represent a substantial number of CD41 T cells.From another point of view, more than 30% of the anti-
body-selected hybridomas reacted with at least one of Based on our data, the highly MHC cross-reactive
clones must be relatively rare, perhaps no more frequentthe 8 MHC haplotypes in thepanel, suggesting that most
clones in the preselection repertoire are reactive with than would be predicted by chance given the observed
distribution of MHC reactivities in the antibody-selectedone or another of the 100 or so murine MHC II molecules
available in nature (Gotze et al., 1980). Many of these repertoire.
It might be argued that the preselection repertoirehybridomas may also be MHC I–reactive, but were not
observed, presumably because the hybridomas do not contains many broadly MHC-reactive clones that were
lost during the preparation of hybridomas. This couldexpress CD8. These data argue strongly that MHC reac-
tivity is inherent in the germline-encoded portions of occur because MHC I (H-2k) and b2m molecules donated
by the BW5147 fusion partner were expressed by thethe TCR, independent of positive and negative thymic
selection. hybridomas; hybridomas reactive with these MHC I mol-
ecules might have been induced to undergo apoptosisThe TCRs in the fetal repertoire contain smaller and
less variable CDR3 regions due to the low levels of and therefore would have been lost from the panel. It
should first be noted that the results of Ignatowicz etterminal deoxynucleotidyl transferase in the fetal thy-
mus. Recent reports raise the possibility that the shorter al. were also obtained with a T hybridoma panel, so this
mechanism cannot account for any differences in theCDR3 regions may confer greater MHC reactivity (Gilfil-
lan et al., 1994; Gavin and Bevan, 1995). Therefore, the results between that study and ours. Second, it is un-
likely that the loss of hybridomas by this mechanism isMHC reactivity of the fetal preselection repertoire, as
assessed in our experiments, may be somewhat higher seriously biasing the antibody-selected repertoire,
based on the independent comparison of MHC reactivitythan that in the adult preselection repertoire.
In recent studies, it was proposed that the alloreactiv- from the LDA experiments. The similar frequencies of
MHC-reactive clones in the LDAs performed with anti-ity observed in the normal repertoire might represent
only the “tip of the iceberg” of all alloreactivity (Ignato- body-selected and MHC-selected repertoires supports
the conclusion that the preselection repertoire exhibitswicz et al., 1996). This suggestion was based on the
observation that among clones positively and negatively a level of MHC reactivity similar to that of the MHC-
selected repertoire and suggests that there cannot existselected by a single peptide\MHC complex, a large frac-
tion exhibited alloreactivity, and an even larger fraction a large number of pan-MHC-reactive clones that were
lost during hybridoma preparation.exhibited reactivity with cells expressing the selecting
MHC molecule complexed with the full array of cellular The results suggest that a minimum of 5.7% of the
preselection repertoire is potentially subject to negativepeptides. This reactivity pattern could arise if these
TCRs bind mostly to conserved MHC residues, with selection in mice of a given haplotype, since that is the
average percentage of clones that reacted with eachonly a small contribution from interactions with peptide
residues. It was suggested that this recognition pattern MHC haplotype. The actual percentage is likely to be
significantly higher than this, since our assays were notwould also result in a higher than expected degree of
reactivity with cells expressing other MHC molecules. suitable for detecting MHC I–reactive clones. Further-
more, negative selection can delete clones that exhibitHowever, our results suggest that cells with multiple
MHC reactivities are not significantly more common in avidity for MHC below the threshold for triggering ma-
ture T cells (Pircher et al., 1991). MHC heterozygosity,the preselection repertoire than would be predicted by
chance, given the observed overall number of MHC re- which is the rule in outbred populations, should lead to
a further doubling of the frequency of cells susceptibleactivities. Furthermore, our data suggest that the fre-
quency of MHC reactivities in general is not significantly to negative selection. Taking all of these factors into
account, we estimate that 20%–30% of thymocytes in aelevated compared to the MHC-selected repertoire.
Even if a larger sample were to show significantly in- typical outbred animal might be susceptible to negative
selection. In a hypothetical mouse expressing all MHCcreased MHC reactivity in the preselection repertoire,
the effect is bound to be small based on the present molecules of the species, the entire repertoire might be
subject to clonal deletion, suggesting an evolutionaryanalysis. Our data are in line with the conclusions of an
analysis of apoptotic cells in the thymus, which failed rationale for the distribution of a few highly polymorphic
MHC molecules to each member of the species, ratherto detect a high level of MHC-induced negative selection
in the normal thymus (Surh and Sprent, 1994). To recon- than having each member express a large number of
different MHC molecules. The fraction of the prese-cile our results with those of Ignatowicz et al., we pro-
pose that thymic selection by a single peptide/MHC lection repertoire that is subject to positive selection
cannot be ascertained from our results.complex results in the enrichment of relatively rare
clones in the preselection repertoire that exhibit strong The inherent MHC reactivity of TCRs leads to the infer-
ence that TCRs interact with MHC molecules in a spe-interactions with conserved MHC residues, and there-
fore excessive cross-reactivity with different MHC mole- cific way(s). Recent structural analyses of TCR–MHC/
peptide complexes suggest that different TCRs may in-cules. The enrichment of these clones occurs because
many of them are not induced to undergo negative se- teract with their different MHC/peptide target com-
plexes with a similar orientation (Brock et al., 1996; Gar-lection by this particular peptide/MHC complex, al-
though they would be deleted in a normal thymus. Thus, cia et al., 1996; Garboczi et al., 1996; Sant’Angelo et
MHC Reactivity of the Preselection TCR Repertoire
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cells were analyzed on a EPICS Excel flow cytometer (Coulter, Hia-al., 1996). Numerous contacts between the TCR and
leah, FL, USA). 2–4 3 104 events were accumulated using forwardconserved MHC I residues were observed primarily in
and side scatter gating to exclude nonviable cells. Graphics werethe CDRa1, CDRa2, and CDRb3 regions of the TCR
generated using the WindMdi program (John Trotter, Salk Insti-
(Garboczi et al., 1996). Evidence that the TCRa CDR1/ tute, USA).
CDR2 regions interact with MHC molecules has also
been recently provided (Sim et al., 1996). It will be inter- Limiting Dilution Analysis
Thymocytes from organ cultures were depleted of CD81 cells byesting to determine whether specific contacts between
use of anti-CD8 MAb AD4(15) ascites and rat anti-mouse IgM-coatedTCR residues and conserved MHC residues underlie the
Dynabeads M-450 (Dynal Inc., Great Neck, NY, USA). The fractionTCR–MHC interaction and account for the inherent MHC
of CD41CD82 T cells in the CD8-depleted fraction was assessed
reactivity of the T cell repertoire. by flow cytometry. Cultures were in 200 ml DMEM/FCS medium
supplemented as described (Ceredig et al., 1983) and containing 15
ng/ml rIL-2 (Chiron Corporation). Graded numbers of thymocytesExperimental Procedures
were plated into round bottom 96-well plates (Costar Corporation)
(24 wells per dilution), followed by the addition of 6–8 3 105 irradiatedMice
(3000 rad) splenic stimulator cells from DBA/1J, C57BL/6 b2m2/2,The C57BL/6 (H-2b)-, B10.BR (H-2k)-, and BALB/c (H-2d) b2m-defi-
or C57BL/6 Ab2/2b2m2/2 mice. After 6–7 days at 378C, 5% CO2,cient (b2m2/2), C57BL/6 Ab-deficient (Ab2/2), and C57BL/6 Ab2/2
cultures were restimulated with 5 3 105 stimulator cells and pulsedb2m2/2 mice have been described before (Zijlstra et al., 1990;
2 days later with 1 mCi [3H]thymidine for 12–16 hr. Cultures in whichGrusby et al., 1993). The B6-b2m2/2 and B6-Ab2/2 mice used to
the incorporated label exceeded by more than 3 SD the mean inprepare MHC IoIIo mice and as stimulator cells had each been back-
negative control wells stimulated with MHC IoIIo stimulator cells werecrossed to B6 five times. HY-TCR-transgenic (H-2b) (Teh et al., 1988)
defined as “positive.” The frequency of MHC-reactive thymocytesand Mtv2 (H-2k) (Scherer et al., 1995) mice were generously provided
was calculated according to the minimum chi-square method byby Drs. H. von Boehmer (Basel Institute for Immunology, Basel,
use of a computer program kindly provided by Dr. D. Cassel.Switzerland) and P. Marrack and J. Kappler (University of Colorado,
CO, USA). HY-TCR-transgenic mice were crossed with C57BL/6
Production and Analysis of T Hybridomasb2m2/2 (MHC IoII1) mice, and the pups were intercrossed to obtain
Thymocytes from organ cultures were depleted of CD81 cells, asHY-TCR1, MHC IoII1 mice. The remaining strains were purchased
described above, and stimulated for 2 days in culture wells of 24-from The Jackson Laboratories (Bar Harbor, ME, USA).
well plates that were coated with 10 mg/ml anti-TCRab MAb H57-
597 and 1/400 dilution of anti-CD28 (37.51) ascites fluid (a gift of
Antibodies
Dr. M.Krummel). Blasts werepurified by Ficoll-Paque centrifugation,From CALTAG (San Francisco, CA, USA), we purchased anti-
washed, fused to BW5147a2b2 cells (White et al., 1989), and selec-CD4-Phycoerythrin (PE) (CT-CD4), anti-CD8/Lyt-2-Fluorescein iso-
tion was performed according to standard protocols. Plating effi-thiocyanate (FITC) (CT-CD8a), anti-CD44/Pgp-1-FITC (IM7.8.1),
ciency of HAT-resistant hybridomas was # 10%, except for the firstanti-CD25/IL-2Ra-FITC (PC61.5.3), anti-gdTCR-FITC (GL.3), and
set (set 1) of hybrids derived from MHCIoII1 fetal thymii, for whichStreptavidin-Tricolor (SA1006). From Pharmingen (San Diego, CA,
it was almost 100%. Clonality of this set of hybridomas was achievedUSA), we purchased biotinylated anti-Vb, anti-Va, and anti-CD69
by subsequent single cell cloning; clonality of most hybridomas in(H1.2F3). From GIBCO (Grand Island, NE, USA), we purchased anti-
all of the sets was indicated by staining with anti-Vb MAbs (seeCD8/Lyt-2-RED613 (#53-6.7). Anti-CD24/HSA (M1/69.16.11. HL)
text). Hybridomas that stained strongly positive for CD4 and abTCRand anti-TCRb (H57-597) hybridomas were purchased from ATCC
and specifically released substantial IL-2 upon abTCR stimulation(Rockville, MD, USA). Anti-HY-TCR (T3.70) (Teh et al., 1988) was
by plate-bound MAb H57-597 were chosen for further analysis.
provided by Dr. H. von Boehmer. The antibodies were purified from
MHC reactivity was assessed by culturing 1 3 105 hybridoma cells
culture supernatants over Protein G Agarose (Boehringer, Indianap-
with 2 3 105 irradiated splenic stimulator cells in 200 ml of complete
olis, USA) and either biotinylated or FITC-conjugated. For addition
RPMI medium for 24 hr. Stimulator cells from MHC IoIIo mice served
to fetal organ cultures, the purified MAb H57-597 in PBS was centri-
as negative controls. For evaluation of IL-2 release, 100 ml of the
fuged for 4 hr at 55,000 rpm (Beckman TLS55), 48C, and sterile-
supernatant was added to 100 ml containing 5 3 103 CTLL-2 cells.
filtered.
The cultures were pulsed after 24 hr with 1 mCi [3H]thymidine for 6
hr. Hybridomas were designated MHC-reactive when thestimulation
Fetal Thymic Organ Culture (FTOC) index in reference to the negative controls exceeded 4.0. The large
Thymii from embryonic day 16 or 17 fetuses were placed in fetal majority of “negative” hybridomas yielded stimulation indices close
thymic organ cultures on 0.4 mm membranes of 24 mm Transwell to 1.0.
plates (Corning Costar Corp.) submersed in 2 ml DMEM (GIBCO,
#11995) supplemented with 10% fetal calf serum (FCS; Sigma, St. Acknowledgments
Louis, MO, USA), 2-ME, nonessential aminoacids, and antibiotics.
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